Clinical trial

Stem Cell Study for Patients With Leg Ulcer/Gangrene

NCT00221143 · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other · Completed

Key facts

NCT number NCT00221143
Title Stem Cell Study for Patients With Leg Ulcer/Gangrene
Official title Phase I / II Clinical Trial Regarding Vascular Regeneration Therapy by Transplantation of Autologous Peripheral Blood Endothelial Progenitor Cells (CD34+ Cells) in No-Option Patients With Chronic Critical Limb Ischemia
Lead sponsor Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other
Collaborators Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan Kobe City General Hospital
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Leg Pain, Ulcer, Gangrene, Ischemia, Peripheral Vascular Diseases
Intervention type Genetic
Interventions Autologous peripheral blood CD34 positive cell therapy
Enrollment 15
Start date Nov 1, 2003
Completion Jan 1, 2008
First posted Sep 22, 2005
Last update posted Feb 9, 2009
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies